hypertension | Research | 6 pages | source: The American journal of cardiology | Added Apr 30, 2019
Do cholesterol-lowering drugs increase diabetes risk?
This study compared the benefits and risks of cholesterol-lowering drugs, statins, on reducing heart problems and increasing the occurrence of diabetes.
benign prostatic hyperplasia | Research | 10 pages | source: BMJ | Added Apr 30, 2019
Are men taking 5α-reductase inhibitors for an enlarged prostate more likely to develop type 2 diabetes?
This study examined if men taking 5α-reductase inhibitors (5ARIs) for benign prostatic hyperplasia (BPH) are more likely to develop type 2 diabetes (T2D). This study concluded the risk of developing T2D is higher in patients taking 5ARIs for BPH, compared to alpha blockers.
hypertension | Research | Treatment | 10 pages | source: Hypertension | Added Apr 28, 2019
Effects of magnesium supplements on blood pressure in hypertensive patients
This study looked the effect of oral magnesium supplements on blood pressure in hypertensive patients. The authors concluded that magnesium supplements can lower blood pressure in adults and may be beneficial for hypertensive patients.
hypertension | Research | Lifestyle | 10 pages | source: International Journal of Cardiology | Added Apr 26, 2019
Can the DASH diet reduce cardiovascular risk in hypertensive patients?
This study examined the benefits of the DASH diet on the risk of cardiovascular disease (heart and blood vessel disease) in patients with hypertension. The authors found no benefit of the DASH over standard recommendations in reducing cardiovascular risk.
hypertension | Research | Treatment | 10 pages | source: High blood pressure & cardiovascular prevention: the official journal of the Italian Society of Hypertension | Added Apr 24, 2019
A review of sacubitril/valsartan effectiveness in hypertensive patients over 55
This study investigated combined treatment with sacubitril/valsartan (Entresto) in patients over 55.
They found that this combination was effective in this group of patients.
benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Neurourology and urodynamics | Added Apr 23, 2019
Effective drug combinations for the treatment of overactive bladder in patients with benign prostatic hyperplasia
This study investigated drug combinations with silodosin (Rapaflo) to treat overactive bladder (OAB) in men with benign prostatic hyperplasia (BPH).
They found that fesoterodine (Toviaz) was more effective than mirabegron (Mirbetriq) as add-ons to silodosin in these patients.
hypertension | Research | Treatment | 10 pages | source: Journal of the American College of Cardiology | Added Apr 22, 2019
Is renal denervation effective in the management of hypertension?
This study reviewed the effectiveness of renal sympathetic denervation (RSD) in the treatment of hypertension. They found that this procedure was effective in reducing blood pressure.
benign prostatic hyperplasia | Research | 10 pages | source: Urology | Added Apr 20, 2019
How widespread are urinary symptoms in the general population?
This study examined the prevalence of benign prostatic hyperplasia (BPH) and urinary symptoms among men in the general population. Researchers reported a considerably high prevalence of urinary symptoms, which was higher among older men, and progressed over 3 years for most men.
hypertension | Research | Treatment | 17 pages | source: Hypertension | Added Apr 19, 2019
Primary aldosteronism causing hypertension; early treatment improves outcomes
This study examined the effect of treatment on blood pressure and heart tissue changes in patients with primary aldosteronism.
hypertension | Research | Treatment | 8 pages | source: PLOS ONE | Added Apr 17, 2019
Beta blockers and hypertension
This study compared the effects of bisoprolol (Zebeta, Concor) and atenolol (Tenormin) on sympathetic nervous activity (SNA) and central aortic pressure (CAP) in patients with essential hypertension.
